Press release
Masimo Announces Expansion of Strategic Partnership with Philips
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation
About this update from Masimo Corporation
[{"type":"text","content":"\nMulti-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA).\n\n\nBuilding on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo’s monitoring technologies, such as industry-leading SET® pulse oximetry, into a variety of Philips multi-parameter patient monitors through 2026 and beyond. This includes integrating Masimo’s Radius PPG® with Masimo-board equipped Philips monitors and next-generation wearable multi-parameter solutions, as well as integrating a range of Masimo sensor technology with all Masimo-equipped Philips bedside monitors and central stations. Philips and Masimo will also work together to strategically develop, produce, and co-promote next-generation artificial intelligence-based monitoring technologies, bringing the benefits of their mutual innovations in the coming years to millions more patients around the world.\n\n\nIn addition to clinically proven SET® pulse oximetry, which is available on Philips patient monitors, numerous other Masimo monitoring technologies are already available on Philips devices, including advanced measurements such as continuous hemoglobin (SpHb®), O3® regional oximetry, SedLine® brain function monitoring, and NomoLine® capnography. As part of their renewed partnership, Philips is expediting adoption of these technologies in additional devices and market segments, increasing their availability to support more clinicians and patient care across the continuum of care.\n\n\n“We are excited to continue to partner with Philips to bring Masimo’s newest innovations in wearables and artificial intelligence to Philips’ platforms,” said Katie Szyman, CEO of Masimo. “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients. Together, Masimo and Philips will continue to empower clinicians to transform patient care.”\n\n\n“Our priority is helping clinicians deliver the best possible care to...